Trial Profile
A randomized, double blind, placebo controlled, multicentric study to assess the efficacy and safety of Udenafil tablets in patients suffering from erectile dysfunction.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Dec 2018
Price :
$35
*
At a glance
- Drugs Udenafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Sponsors Cadila Healthcare
- 12 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India record.
- 02 Aug 2010 New trial record